Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies: a meta-analysis based on cardiovascular outcomes trials.

Abd El Aziz, Mirna; Cahyadi, Oscar; Meier, Juris J; Schmidt, Wolfgang E; Nauck, Michael A

Abd El Aziz, Mirna; Cahyadi, Oscar; Meier, Juris J; Schmidt, Wolfgang E; Nauck, Michael A.

Afiliación

Abd El Aziz M; Diabetes Division, Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstraße 56, D-44791, Bochum, Germany.
Cahyadi O; Diabetes Division, Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstraße 56, D-44791, Bochum, Germany.
Meier JJ; Diabetes Division, Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstraße 56, D-44791, Bochum, Germany.
Schmidt WE; Diabetes Division, Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstraße 56, D-44791, Bochum, Germany.
Nauck MA; Diabetes Division, Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Gudrunstraße 56, D-44791, Bochum, Germany.

Diabetes Obes Metab ; 22(4): 699-704, 2020 04.

Article en En | MEDLINE | ID: mdl-31750601

Asunto(s)

Diabetes Mellitus Tipo 2; Inhibidores de la Dipeptidil-Peptidasa IV; Neoplasias; Pancreatitis; Enfermedad Aguda; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/epidemiología; Inhibidores de la Dipeptidil-Peptidasa IV/efectos adversos; Receptor del Péptido 1 Similar al Glucagón; Glucosa; Humanos; Hipoglucemiantes/efectos adversos; Incretinas/efectos adversos; Pancreatitis/inducido químicamente; Pancreatitis/epidemiología; Estudios Prospectivos

Palabras clave

DPP-4 inhibitors; GLP-1 receptor agonists; cancer; cardiovascular outcomes trials (CVOTs); dipeptidyl peptidase-4; glucagon-like peptide (GLP-1); incretin-based medications; neoplasms; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pancreatitis / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google